{"database": "lobbying", "table": "lobbying_activities", "rows": [[1545772, "b972730c-965d-43d8-a292-1a5313a3e414", "Q2", "CSL BEHRING LLC", 308935, "CSL BEHRING LLC", 2014, "second_quarter", "HCR", "Preserving Access to Orphan Drugs Act (HR 2315/S.1128)\nOrphan Drug Tax Credit - highlighting its importance in orphan product development for treatment of rare diseases", "HOUSE OF REPRESENTATIVES,SENATE", null, 170000, 0, 0, "2014-07-02T10:20:19.063000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1545772"], "units": {}, "query_ms": 9.124233038164675, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}